Pharma Raw Materials Injectable Polypeptide Growth Hormone Releasing Peptide Seractide 12279-41-3 for Heighten Usage Adrenal Insufficiency
Quick Details for Seractide
Product Name: Seractide
Alias: CORTICOTROPIN (HUMAN);CORTICOTROPHIN;CORTICOTROPIN A;H-SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-ASN-GLY-ALA-GLU-ASP-GLU-SER-ALA-GLU-ALA-PHE-PRO-LEU-GLU-PHE-OH;ACTH (1-39), HUMAN;ACTH 1-39;ACTH;ADRENOCORTICOTROPIC HORMONE HUMAN
CAS: 12279-41-3
Molecula Formula: C207H308N56O58S1
Molecula Weight: 4541.07
EINECS: 232-659-7
Appearance: White freeze-dried powder
Assay: 99.0%
Grade: Pharmaceutical grade
Specification: 10mg/vial
Minimum Order Quantity: 1000vials
Product Categories: Peptide; Melanocortin receptor
Storage Temp.: −20°CSolubility H2O: 1 mg/mL, clear, colorlessUsage: seen in stress states, primary adrenal insufficiency, Cushing syndrome, Nelson syndrome, congenital adrenal hyperplasia, pituitary adrenocorticocytoma.
Product Description
Seractide is potent endogenous melanocortin receptor 2 (MC ) agonist (EC = 57 pM). Component of the hypothalamic-pituitary-adrenal (HPA) axis that stimulates glucocorticoid production and release from the adrenal cortex. Induces insulin resistance, promotes a proinflammatory profile and stimulates UCP-1 in adipocytes in vitro.
Product Applications:
1) Endocrine Disorders: Nonsuppurative thyroiditis; Hypercalcemia associated with cancer.2) Nervous System Diseases: Acute exacerbations of multiple sclerosis.3) Rheumatic Disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation).4) Collagen Diseases: During an exacerbation or as maintenance therapy.5) Dermatologic Diseases: Pemphigus; bullous dermatitis herpetiformis.6) Allergic States: Control of severe or incapacitating allergic conditions.7) Ophthalmic Diseases: Severe acute and chronic allergic and inflammatory processes.
0 likes
China [CN] 
Click enlarge Image